Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Food may taste different on GLP-1 drugs, but taste may not be the reason

4

Aug 2026

Food may taste different on GLP-1 drugs, but taste may not be the reason

The review suggests that patient-reported “taste changes” during GLP-1RA treatment may reflect reduced food enjoyment and motivation rather than consistent impairment of basic taste. The authors propose a sensory-liking-wanting framework while emphasizing that current human evidence remains heterogeneous and largely indirect.

Airplane wastewater pilot shows how airports could track pathogens across borders

4

Aug 2026

Airplane wastewater pilot shows how airports could track pathogens across borders

Researchers showed that airplane wastewater from a shared US-UK transatlantic route could be collected and analyzed to detect respiratory and enteric pathogen genetic material. The pilot also captured SARS-CoV-2 lineage patterns, including earlier detection of XEC on UK-origin flights, while showing the need for harmonized assays and broader sampling.

Study links lower vitamin D to mood and cognitive health in adults over 85 with diabetes

3

Aug 2026

Study links lower vitamin D to mood and cognitive health in adults over 85 with diabetes

Researchers studying 188 adults aged 85 years or older with type 2 diabetes found the lowest serum 25(OH)D concentrations among those with both depressive symptoms and mild cognitive impairment. Lower levels remained associated with having both conditions after adjustment for selected factors, but the cross-sectional study cannot establish causation or a benefit from supplementation.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.